2020
Search results
statnews.com
- Emmanuelle Charpentier (born December 11, 1968, Juvisy-sur-Orge, France) is a French scientist who discovered, with American biochemist Jennifer Doudna, a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.
www.britannica.com › biography › Emmanuelle-Charpentier
People also ask
Who are Emmanuelle Charpentier & Jennifer Doudna?
How much is Emmanuelle Charpentier worth?
How did Emmanuelle Charpentier and Jennifer Doudna create high-precision genome editing?
Emmanuelle Marie Charpentier (French pronunciation: [emanɥɛl maʁi ʃaʁpɑ̃tje]; born 11 December 1968) is a French professor and researcher in microbiology, genetics, and biochemistry. As of 2015, she has been a director at the Max Planck Institute for Infection Biology in Berlin.
May 10, 2024 · Emmanuelle Charpentier (born December 11, 1968, Juvisy-sur-Orge, France) is a French scientist who discovered, with American biochemist Jennifer Doudna, a molecular tool known as clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9.
- Kara Rogers
Emmanuelle Charpentier, is a French microbiologist, geneticist and biochemist. She has developed her scientific career in academic research institutions in France, the United States, Austria, Sweden and Germany.
As new molecular and cellular technologies became available in the early 1990s, I turned my focus to the study of how bacterial pathogens infect and interact with their hosts and environment. I studied molecular mechanisms of regulation involved in gene and protein expression during infection.
Emmanuelle Charpentier. The Nobel Prize in Chemistry 2020. Born: 11 December 1968, Juvisy-sur-Orge, France. Affiliation at the time of the award: Max Planck Unit for the Science of Pathogens, Berlin, Germany. Prize motivation: “for the development of a method for genome editing”. Prize share: 1/2.
Emmanuelle is the inventor and co-owner of the core intellectual property of the CRISPR-Cas9 technology. Together with Rodger Novak and Shaun Foy, she co-founded CRISPR Therapeutics and ERS Genomics to develop the CRISPR-Cas genome engineering technology for biotechnology and biomedical applications.
In this interview recorded shortly after news broke of her Nobel Prize in Chemistry, Emmanuelle Charpentier tells Adam Smith of her surprise at receiving the call from Stockholm, despite considerable speculation that it might be coming her way.
Related searches
Movies & TV Shows
Searches related to emmanuelle charpentier biography
